From Pandemic Urgency to Practical Impact: How Diagnostics Investment Priorities Are Evolving

When the Covid-19 pandemic hit, molecular and rapid diagnostics received unprecedented attention and funding. What became essential then for adoption was speed, and speed still matters, but there’s been a shift in the industry. It’s not enough to be scientifically sound. Now, practicality is of utmost importance. This is the priority that anyone involved with […]